Cellectar Biosciences has extended its collaboration with Pierre Fabre, a French pharmaceutical company, the company announced today. “The extension of our research agreement with Pierre Fabre allows us to further…
The U.S. Patent and Trademark Office has awarded Lucigen a patent for its pJAZZ BigEasy System, the company announced recently. According to a release, the pJAZZ system offers the unique ability…
The U.S. Patent and Trademark Office awarded SHINE Medical Technologies a patent that relates to producing medical isotopes, the company announced recently. “This patent protects our technology in America, which…
Cellular Dynamics International (CDI) and Nanion Technologies, a leading provider of instrumentation for ion channel drug discovery and screening, announced they have entered into a joint marketing agreement. According to a…
Cellectar Biosciences announced today it has entered into a strategic collaboration with Onconova Therapeutics, a biopharmaceutical company, to develop new phospholipid drug conjugates (PDC). According to a release, the Newtown,…
Gregor Diagnostics announced today a licensing agreement for intellectual property with the Wisconsin Alumni Research Foundation. According to a release, the molecular diagnostics company will have exclusive rights to biomarkers that…
Stemina Biomarker Discovery is preparing to go to market in early 2018 with its autism diagnostic test panel, the company announced recently. According to a release, Heiner Dreismann, the former head…
Story provided by Alex Moe, WisBusiness.com A Madison-based biotech startup with ambitious goals is adding staff and expanding testing capabilities as it seeks early-stage investment. JangoBio is trying to develop…
Propeller Health has extended its 2015 collaboration with GlaxoSmithKline (GSK) to improve management of asthma and COPD, the company announced recently. “We are excited to be working closely with GSK…
Cellectar Biosciences‘ Phospholipid Drug Conjugate (PDC) research program has generated numerous PDC molecules that show “significant” improved pharmacologic activity, the company announced today. According to a release, Cellectar’s research demonstrates that…
